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background: Chronic total occlusion (CTO) lesions, especially long CTO lesions were still challenging in percutaneous coronary 
intervention (PCI) even with second generation drug eluting stents (2nd DES). Our aim in this study was to compare the results of full metal 
jacket with 2nd DES for CTO lesions and non-CTO lesions.
methods:  We studied 265 consecutive patients (265 lesions) who underwent full metal jacket with 2nd DES implantation (everolimus-, 
biolimus- and zotarolimus-eluting stents). In this study, full metal jacket was defined as overlapping DES measures>50mm. 102 patients 
underwent DES implantation for CTO lesions (CTO group) and remaining 163 patients underwent DES implantation for non-CTO lesions 
(non-CTO group). Outcome measures were target lesion revascularization (TLR), stent thrombosis (ST), myocardial infarction (MI), all 
cause of death and major adverse cardiac cerebrovascular event (MACCE) during follow-up were compared between two groups.
results:  People in CTO group were younger than non-CTO group (65±11 vs 70±11, p<0.01) but percentage of age>80 was similar 
between two group (8.8% vs 16.5%, p=0.07). Percentage of male was higher in CTO group than non-CTO group (88% vs 75%, p=0.03). 
Lesions including left main trunk were significantly lower in CTO group than non-CTO group. (1% vs 5.5%, p=0.04). Other patient 
background and lesion characteristics were similar between two groups. In follow up term (24.2±12.3 months), the incidence of TLR (CTO 
17.4% vs non-CTO 19.8%, p=0.93), ST (CTO 0% vs non-CTO 1.1%, p=0.17), MI (CTO 5.9% vs non-CTO 3.9%, p=0.30), death (CTO 7.6% 
vs non-CTO 14.8%, p=0.50) and MACCE (CTO 7.8% vs non-CTO 11.1%, p=0.60) were similar between two groups.
Conclusion: The efficacy and safety of full metal jacket with 2nd DES for CTO lesions was similar for non-CTO lesions.
